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Abstract
Magnetic resonance and computed tomography imaging aid in the diagnosis and analysis of patho-
logic conditions. Blood flow, or perfusion, through a region of tissue can be computed from a time
series of contrast-enhanced images. Perfusion is an important set of physiological parameters that
reflect angiogenesis. In cancer, heightened angiogenesis is a key process in the growth and spread
of tumorous masses. An automatic classification technique using recovered perfusion may prove
to be a highly accurate diagnostic tool. Such a classification system would supplement existing
histopathological tests, and help physicians to choose the most optimal treatment protocol. Per-
fusion is obtained through deconvolution of signal intensity series and a pharmacokinetic model.
However, many computational problems complicate the accurate-consistent recovery of perfusion.
The high time-resolution acquisition of images decreases signal-to-noise, producing poor decon-
volution solutions. The delivery of contrast agent as a function of time must also be determined or
sampled before deconvolution can proceed. Some regions of the body, such as the brain, provide
a nearby artery to serve as this arterial input function. Poor estimates can lead to an over or under
estimation of perfusion. Breast tissue is an example of one tissue region where a clearly defined
artery is not present. This proposes a new method of using recovered perfusion and spatial infor-
mation in an automated classifier. This classifier grades suspected lesions as benign or malignant.





Cancer is disease of unchecked cell division that is a leading cause of death for persons under
85. Exposure to carcinogenic compounds, dietary content, genetic predisposition, and age are
all variables that may increase an individual’s risk of developing cancer. Over 200 variants affect
nearly every bodily system, for which different screening procedures and treatments are employed.
Different sectors of the population are more susceptible to certain forms of cancer. Breast cancer,
the focus of this study, is the second most common form after lung cancer, and accounts for a third
of all new cases of cancer in females [JMW+05].
Cancerous cells invade healthy tissues and interfere with their normal function. Lymphoma, for
example, attacks the immune system and hinders the body’s ability to ward off infection. A tumor
may develop and remain benign, not spreading from its point of origin. However, if a portion of a
tumor breaks from the main mass and spreads to other parts of the body, that tumor is said to have
metastasized. These metastacized cells may invade different tissues and grow into new tumors.
Early detection and treatment is key to a patient’s survivability of the disease. Physicians may
treat the patient with a combination of drug therapy, radiation therapy, and/or surgical removal of
the tumor. Attacking the cancer with the least amount of damage to healthy tissue requires accurate
diagnostic information from histopathological analysis, serological analysis, and other diagnostic
tools such as medical imaging.
Though biopsy is ultimately the gold standard for cancer diagnosis, medical imaging is a valu-
able tool for gathering information in vivo for both screening and diagnosis. Radiologists are able
interpret this imagery and recognize characteristics associated with cancer morphology. Accu-
rate interpretation of the imagery assists in determining the best actions for further analysis and
treatment.
There are a number of tools for breast imaging. X-ray mammography transmits a dose of radi-
ation through the breast tissue, and captures the projected image on film or digital medium. Com-
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puted tomography (CT), generates a 3-dimensional volume by aggregating 2-dimensional slices.
Measures are taken to mitigate the patient’s exposure to radiation. Magnetic resonance imaging
(MRI) manipulates the spin and orientation of mostly hydrogen atoms in the tissue, differentiating
the soft tissues in the body by this water content. These imaging processes are powerful aids for
location and characterization of abnormal conditions.
Beyond morphology, perfusion, the flow of blood through tissue, may reveal a great deal of
information about a suspected tumor. Tumors larger than a few millimeters require additional
vasculature to deliver oxygen and nutrients to sustain this growth. The new blood vessels exhibit
irregularities that allow larger molecules to pass into the extravascular space. By adding indicator
particles into the blood stream, this “leakage” behavior can be captured and compared to how
cancerous tissue has been observed to respond.
To acquire contrast-enhanced perfusion imagery with MRI, the patient is injected with a para-
magnetic contrast agent, such as gadolinium or feroglucose. The tissue is imaged over time as the
contrast agent circulates through the body. As the contrast arrives on the tumor periphery, the MRI
may register a signal change at each tissue voxel. Signal analysis of this time series can character-
ize the rate of blood flow, the volume of the leakage space, and how long any individual indicator
particle takes to traverse a unit volume. Our study uses the contrast-enhanced imagery produced
by the VIBRANT protocol (Volume Imaging for BReast AssessmeNT, General Electric).
Computing these perfusion characteristics for known healthy, benign, and malignant test cases
generates a great quantity of data to train a judiciously chosen machine learning algorithm. New
cases could then be classified in both screening and diagnostic roles. It is our goal to understand
this enhancement process, compute perfusion parameters, and construct a classification framework
that produces a machine-generated prediction. Such a framework would be a valuable step in
building the next generation of computer-aided diagnostic tools in the domain of cancer research.
We will present the parts of this framework that have the greatest impact on improving detection
and classification accuracy.
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This research addresses several challenges in designing a classification framework. Computa-
tional perfusion recovery must be able to handle low signal-to-noise, image registration artifacts,
as well as physiological variations between patients. We will examine the signal enhancement as
the convolution of an arterial input function (AIF) and a tissue response kernel. The perfusion
parameters of flow, volume, and mean transit time are obtained from this tissue kernel. The arterial
input function is selected from a fitted pharmacokinetic model (e.g., Toft’s), or sampled from an
adjacent blood vessel in the image series.
Several options for the training and classification are explored that exploit the recovered per-
fusion information. Cluster analysis and statistical learning methods are applied to a feature space
that we developed, and the results are compared to the model-based three time-points (3TP) method
for enhancement analysis. As the name suggests, the 3TP method reduces the enhancement curve
to information to three time points. We found that incorporating additional information in the
classifier training yields better performance in terms of accuracy.
Chapter 2 presents a foundation of current research on this topic examining the physiology
of cancer growth, methods of cancer imaging with emphasis on MRI, the perfusion convolution
model, and machine classifiers applied to medical diagnosis.
Chapter 3 describes the nature of the experimental data and develops the method for perfusion
recovery by deconvolution. The types of pathology found in the experimental data are also pre-
sented. Chapter 3 poses the feature vector construction used for classification. The outline for a
procedure to train and test machine learning algorithms, such as the k-nearest neighbor and support
vector machine learners is presented.
Chapter 4 organizes the results of the various training methods and classifier results in terms
of accuracy, specificity, sensitivity, and clinical observations by a radiologist.
In Chapter 5, the performance of the classification framework results is discussed in the larger




2.1 Cancer Detection and Diagnosis
2.1.1 Overview
Early detection of cancer greatly increases the probability of survival for a patient. For cancers of
the breast, the American Cancer Society recommends annual mammography screenings for women
after the age of 40 [ZACS01]. If a suspicious lesion is identified in a initial screening, a physician
may employ other methods to characterize what that lesion may be. Evidence may support further
action where part or all of the lesion is removed in a biopsy procedure for pathological analysis.
Here, at a microscopic scale, the tissue is scrutinized for tell-tale signs of cancer. Figure (2.1)
shows a basic diagnosis and treatment procedure for breast cancer.
Malignant
Needle biopsy
Follow−up High resolution MRI
Chemotherapy
Lumpectomy




Figure 2.1: Typical breast cancer screening and treatment using MRI (Harms, 1994, Figure 3)
Tissue biopsy followed by pathological analysis remains the gold standard for cancer diagno-
sis. Pathologists produce a highly accurate diagnosis by analyzing the microvascular structure and
cellular characteristics of the tissue. Under certain conditions where invasive cancer is suspected,
the physician may recommend that the entire mass is removed in a surgical biopsy. When the
classification of a lesion is unsure, fine needle aspiration biopsy is a less invasive option to sur-
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gical biopsy that can also produce a highly accurate diagnosis. In this procedure, a small needle
is inserted into the mass, extracting cells to be examined. Upon microscopic examination, the
determination of benign, malignant, or uncertain for either, is made. The combination of several
diagnostic tools, used together, can greatly reduce the risk of missing a positive case for cancer
[LAC01].
Preempting an unnecessary surgical procedure not only avoids the usual patient risks and cost
of surgery, but may also possibly prevent triggering further tumor growth. Protein factors that
promote cell division are released during the wound healing process and may inadvertently trigger
a tumor to regrow. To mitigate this risk, drugs that selectively inhibit some cell regrowth might be
administered to the patient. One such post-operative drug, Bevacimuzab, binds to VEGF (vascular
endothelial growth factor), inhibiting the growth of new blood vessels.
Providing the physician more information from pre-surgical techniques, such as with diagnos-
tic imaging, can only improve the decisions made for patient treatment. The following sections
develop the background to understand how diagnostic imaging can be used by a computer-aided
method to perform breast cancer detection and classification. Computer-aided diagnostic imaging
will not replace the gold standard methods soon, but may reduce the cost and time for analysis of
the raw data. A combination of different methods could improve determining the number, location,
and classification of any suspicious lesions.
2.1.2 Physiological Characteristics
The predominant form of cancer found in the breast occurs in the lining of the lactiferous ducts that
transport milk from the mammary lobes to the nipple. The early form of this condition, having not
broken through the endothelial lining of the duct, is referred to as pre-cancerous ductal carcinoma
in-situ. If the tumor continues to grow and breaks through the endothelial lining, the condition
becomes ductal carcinoma invasive, and may spread into surrounding tissues. A tumor is said to
have metastasized if a part of the tumor breaks off and begins growth in another part of the body.
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Tumors which grow to larger than several millimeters require vascular support. Angiogenesis,
the process of growing new blood vessels, normally occurs during wound healing and healthy
tissue growth. New vessels sprout from existing vessels when signaled by growth factors. In a
scenario that might involve a tumor, abnormally heightened angiogenesis could indicate invasive
behavior or the possibility of metastasis [LMS+05, ELPC+03].
The vasculature in the neighborhood of a tumor is also discernible from normal vasculature,
possessing more fenestra, or openings [CP04]. This increased fenestration is likely due to ele-
vated secretion of vascular endothelial growth factor (VEGF) by tumorous tissue [RP95]. As a
consequence, larger molecules can pass from the blood into the extravascular space, or leakage
space [Pad03, DLRH+03]. This increased exchange of macromolecules is used by certain imaging
techniques, described later. The microvascular density (MVD) is another metric that quantifies
the blood vessels present in a unit of tissue volume [MSTK99, MCT+02]. Research in serological
methods attempt to detect specific antigens in bodily fluids that might signal the presence of cancer
[OC98].
Benign growths that do not become invasive are most likely to be fibroadenoma [WSC+99].
Fibroadenoma exhibit a lower microvascular density, and are typically composed of fibrous and
glandular tissue. Fibroadenoma may be discovered by palpation, and subsequently be examined
for any evidence of growth. Microcalcifications are also a benign phenomenon that may be imper-
ceptible to the touch, yet may appear as opaque specks on a breast mammogram [PFL05]. Breast
cysts are another benign, fluid-filled structure that usually do not require treatment after diagnosis.
The physician is tasked with discriminating between these different abnormal conditions. De-
pending on the imaging protocol used, benign conditions and malignancy could be very difficult




A brief survey of existing diagnostic imaging protocols clarifies the challenges in constructing a
computer-aided classification framework. The accuracy of a diagnostic test is a combination of
its correctly predicted disease-present and disease-free conditions (true-positives T+, and true-
negatives T−), as well as the number of mispredicted disease-present and disease-free conditions
(false-positives F+, and false negatives F−) equation (2.1). The sensitivity of a diagnostic equa-
tion (2.2) reflects how likely a test is to miss a disease-present condition. Conversely, specificity
measures the rate at which the test is fooled by a disease-free state equation (2.3). Both metrics are













In 2-dimensional mammograms, physicians have a standard vocabulary for describing the mor-
phological and visual characteristics of a feature in a mammogram (Figure 2.2). Such a lexi-
con collects terms for categorizing the shape, number, and density of tumors in a mammogram
[BKF96]. The Breast Imaging Reporting and Data System (BI-RADS), for instance, defines terms
for a lesion’s margin, mass, calcification distribution, and other features that might be observed
in a mammogram. For example, “spiculated,” “circumscribed,” and “lobular” might describe the
boundary of a lesion. These qualitative descriptions have been correlated to the actual disease con-
ditions, and establish a standard of communication between radiologists. However, because of its
2-dimensional nature, the structures may overlap and obscure other features.
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Figure 2.2: Morphologic features of a malignant tumor (left) and benign features (right) (Orel,
1998, Figure 3)
The screening and diagnostic performance of mammography alone is largely influenced by the
radiologist’s interpretation. In one study, 10 radiologists read 150 mammographic studies each and
rated these visual characteristics. For some characteristics, such as calcification distribution, the
radiologists’ assessments had substantial agreement. There was much more variance in categoriz-
ing lesion shape and density. The results also showed higher agreement between radiologists who
had received the same training. While there is a proven value for manual interpretations of mam-
mography, there is notable variability in specificity and sensitivity depending on a radiologist’s
training [EWL+94].
Radiologists employ other means of imaging for screening and diagnosis: computed tomogra-
phy (CT), ultrasound, positron-emission tomography (PET), and magnetic resonance (MR) [BBH+99,
SAS00]. Each method is subject to conditions that might introduce artifacts. Poor registration from
movement or respiration is more likely to affect an imaging protocol with a longer acquisition time.
When a contrast agent is administered prior to a longer-term imaging process, there are effects that
arise from recirculation. Both spatial and temporal resolution have a pronounced affect on the level
of signal-to-noise in CT and MRI [Mil03].
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Characterization of choline metabolism with MR spectroscopy (MRS) has also been shown to
differentiate benign and malignant lesions [Yeu01, KBSRS+02]. Choline is an essential nutrient
produced during lactation. But in the presence of malignant cancer, increased levels of choline
and choline metabolites might be used as a marker. The levels of choline metabolites detected by
MR spectroscopy can be mapped on to a 3-dimensional volume as a visualization and diagnosis
aid. This method can improve specificity of breast cancer detection when coupled with contrast
enhanced MRI.
Combining information from a variety of imaging methods may improve accuracy. [MSSS+96]
has explored the integration of conventional mammography, sonography, and contrast-enhanced
MRI for cancer diagnosis. Investigators evaluated each test case in each imaging method indepen-
dently, classifying each study as being disease-free, having a benign lesion, or having a malignant
lesion. Specificity was the most improved metric by using this multi-method diagnosis when com-
pared with pathological findings.
No non-invasive diagnostic imaging technique should be used in isolation when considering
risk of a false-negative prediction. When presented with uncertainty, treatment still tends towards
using the gold-standard method of biopsy and pathological analysis. Regardless, imaging pro-
vides a great deal of information. The imaging of contrast-enhanced MRI is especially useful for
characterizing perfusion, which is sought to be a highly accurate screening and diagnostic method.
2.1.4 Perfusion Analysis
Perfusion estimates computed from contrast-enhanced imagery is an effective, non-invasively way
to gauge vascularity [CP04, POM+09]. Ultimately, perfusion can be used to determine how likely
a tumor is to metastasize [Pad99]. In addition to detection and diagnosis, perfusion can be used
to monitor the effectiveness of anti-angiogenic cancer treatments. Bevacimuzab, mentioned in
Section 2.1.1, inhibits the growth of new vasculature, though not directly attacking the tumor
[GPM+03]. Depriving the tumor of oxygen and nutrients slow maturation and may encourage
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regression. Perfusion imaging, in this case, would show the drug affect over successive imaging
sessions.
Each volume element, or voxel, is the smallest unit of resolution in an MR image. By re-
covering the “amount” of perfusion, in relative terms, the blood flow through the tissue can be
color-mapped on the image. These maps illustrate areas of elevated perfusion, found near tumors,
and depressed perfusion, such as in necrotic tissue. Absolute perfusion, in units of fluid per unit
tissue per unit time, is difficult to quantify accurately. Relative perfusion can show comparative
differences in adjacent tissues, which may be as valuable in a diagnostic sense.
Figure 2.3: Pre-Contrast breast (left) tumor imagery followed by post contrast. Relative blood flow
(right) is colored from blue (low) to yellow (high). (Padhani, 2003, Figure 4, 5)
With basic understanding of breast cancer physiology, particularly tumor vasculature charac-
teristics, the methods of relative perfusion recovery can be explained. The process of contrast
administration, circulation and imaging are described then related to the indicator-diluter model,
central volume theorem, and convection-diffusion model. Here, a formulation of perfusion as a
convolution equation is presented and solved analytically.
2.1.5 Detection in MRI
The exploitation of magnetic resonance physics for imaging is a complex phenomenon and a rudi-
mentary understanding of its mechanics is important to how the experimental data will be ad-
dressed. MRI exploits the fact that the majority of body mass is water, and therefore has a large
proportion of hydrogen. MRI for medical imagery uses a specific radio frequency pulse that ex-
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cites the hydrogen atoms, then detects the signal strength of energy released that is released as the
hydrogen atoms “relax.” Because different tissues have differing quantities of water, an image can














Figure 2.4: a. Hydrogen nuclei at equilibrium is excited by RF pulse, b. Magnetic moment vector
is deflected from equilibrium, c. Exponential decay of energy as spin returns to equilibrium, d.
Precession occurs about the Z-axis, used in spin encoding e. Magnetic field linear gradient used in
phase encoding
At the quantum level, each nuclear particle possesses a spin direction, and a magnetic moment
vector associated with this spin. When the body is placed in the magnetic field of the MRI, the
magnetic moments of the hydrogen nuclei will align with this field in a quantity proportional to the
field strength and temperature. A group of hydrogen spins experiencing the same magnetic field is
referred to as a spin packet, which has a net spin vector. When aligned with the magnetic field, a
spin packet is typically in its low-energy, equilibrium state. A radio pulse with a frequency specific
to hydrogen will be absorbed and cause it to deflect to a higher energy orientation. This frequency
is the Larmor frequency, and for hydrogen this value is ν = 42.85MHz/T .
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After this excitation, the energy will decay exponentially and realign with the magnetic field.
By convention, the coordinate system is aligned such that the positive Z-axis is in the direction
of the magnetic field. The time needed to return the magnetic moment vector in the direction
of the magnetic field by a factor of e is the spin-lattice relaxation time, T1. This is described in
equation (2.4) where Mz the magnetic moment in the direction of the magnetic field, M0 is the
initial magnetic moment, t is elapsed time, and T1 is a characteristic of the tissue being examined.
Mz = M0(1− e−t/T1) (2.4)
The relaxation time of the magnetic moment in the transverse plane (XY) is similarly rep-
resented, and referred to as the T2 spin-spin relaxation time. Because of the orientation of the
coordinate system, the transverse magnetic moment vector is at maximum after a 90◦ excitation,
then decays to 0 as the spin realigns with the magnetic field. It holds that T2 ≤ T1. equation (2.5)
describes this as a function with respect to time.
Mxy = Mxy0e
−t/T2 (2.5)
Due to slight variations in the magnetic field, or inhomogeneities, there is a T ∗2 relaxation time










Other mechanisms are used to spatially localize each pixel in 2-dimensions in an MR image
slice. As a spin packet is excited from equilibrium, the magnetic moment vector will also rotate, or
precess, about the Z-axis at a frequency corresponding to the frequency of excitation. By manipu-
lating the magnetic field as a linear gradient along either the X or Y axis, the spin packets can be
differentiated by their rate of spin. If the magnetic field is turned off, these spin packets will halt
and continue to decay energy as an RF signal. As these signals are detected in the RF receiver, each
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pixel location has a characteristic phase and frequency encoding that can be separated by Fourier
methods.
The RF pulses and magnetic field activations are executed in specific imaging sequences that
vary frequency and timing. Generally, there are three timing subintervals that can be manipulated:
repetition time (TR), inversion recovery time (TI), and spin-echo time (TE). There is a marked
difference in how tissues will contrast with each other when these parameters, TE, TR, and TI are
varied. Different kinds of tissue, like fat, bone, and blood vessels, will have different characteristic
relaxation curves values for T1, T2, and T ∗2 . Specific combinations of TR, TI, and TE will cause an
intensity difference between tissues with different relaxation times.
A sequence that maximizes contrast between tissues with differing T1 values is referred to as
a T1-weighted image. Tissues with a short T1 will appear brighter on a T1-weighted image than a
tissue with a longer T1. However, there may be certain kinds of tissue that can be better represented
with a T2-weighted or T ∗2 -weighted imagery. Even greater image contrast can be achieved when a
weakly magnetic material is added to some tissues. This is the basis for contrast-enhanced MRI,
and a contrast agent specially selected for breast tumors would show a unique enhancement pattern.
Prior to MRI acquisition, a contrast agent is often administered to the patient by mechanical
injection. The central concept behind tumor perfusion imaging is that the fenestrae, or openings,
present in the tumor vasculature are large enough to accommodate these macromolecules to travel
into the extravascular space. Experiments have determined that large molecular-weight contrast
agents are more effective at measuring endothelial permeability [LLBT+05]. For MRI, a param-
agnetic contrast agent such as gadolinium chelates is typically chosen. Each gadolinium atom is
sequestered in a ligand structure to render it safe.
A pre-contrast image is acquired before contrast administration. Then, the contrast is injected
and circulates from the injection point to the heart and lungs, then out into the body. After some
elapsed time, the contrast arrives at the breast tissue and to any lesions that may be present. The
expectation is that the gadolinium will accumulate in the leakage space in the vicinity of a tumor.
A higher degree of permeability to the contrast may correlate with an invasive or metastasized
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tumor. Over time, as blood continues to circulate, the accumulated contrast will be taken back into
the blood stream.
The extravascular, extracellular space (EES) in each unit of tissue is filled with fluid that affects
the rate of contrast accumulation and uptake [YLL+05]. This proportion of EES to non-EES
space is called the extracellular volume fraction, or EVF. There is a single-compartment and a two
compartment fluid model that attempt to model this behavior.
2.1.6 Three Time-Points (3TP) Method
The standard method of correlating a signal enhancement curve from contrast to values of EVF
and tissue permeability is the 3-Time Points method (3TP). 3TP is employed in many MRI CAD
systems, such as the GE CadStream product. 3TP examines the ramp-up behavior as the contrast
agent arrives at a tissue voxel (Figure 2.5) [Kuh99, Ore98]. By fitting a pharmacokinetic model
with three specifically chosen time points, the tissue permeability and extracellular volume frac-
tion coefficients can be mapped with a 3-color scheme that can indicate a suspicious condition
[KRV+00]. Tissue segmentation using 3TP has been explored using basic morphological opera-
tions, such as erosion and dilation [LKP+08a].
The creation of the 3TP enhancement map can be generalized by the following method. Three
time points are chosen, typically the pre-contrast, contrast arrival, and post-contrast. For each
voxel based on these three time points, it is binned into three curve types based on basic curve
shape (Figure 2.5).
3TP assigns a color and intensity that indicates membership with three curve families. Type I
curves exhibit a monotonic increase throughout the time series. Type II curves exhibit signal in-
crease from the first to second time point, then remains relatively constant. Type III curves exhibit
a signal increase between the first two time points, then a “wash-out” phase between second and
third time points where there is an intensity decrease. Generally, voxels with a Type II curve are
associated with tissue in a benign mass, whereas Type III curves may be suspect for an invasive



















Figure 2.5: 3TP Time-intensity curve types. Type I shows a gradual signal increase. Type II is
described as a plateau. Type III shows a sharp washout. Time points (a), (b), and (c) are pre-
contrast, contrast arrival, and post-contrast time points, respectively.
sion behavior, and perfusion parameter recovery, with a goal of being able to exploit the remainder
of the signal series for use in a classifier.
Algorithm 1 The 3TP Algorithm
for all Voxel v ∈V do
Let the first intensity change α = t1− t0
if α > 0 then




if β > 0.1 (increases by more than 10%) then
Let blue intensity B = α
else if β < 0.1 (decreases by more than 10% then
Let red intensity R = α
else




The voxel color C← (R,G,B)
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2.1.7 Indicator-Diluter Model
In the simplest of perfusion models, each measurable unit of tissue is represented as a fixed volume
with a single constant inflow and single constant outflow of fluid. In the imagery, this is the smallest
unit of tissue that can be measured in one volumetric pixel. The fluid in this model is blood mixed
with the injected contrast agent, or indicator that can be described as the concentration of indicator
per fluid unit. Zierler developed the indicator-diluter theory that is the basis for current models of
perfusion [Zie62]. As described, Zierler represents a single fluid compartment fed by a input artery
and drained by a output vein (Figure 2.6).
Tumor VolumeArterial Input Venous Output
Figure 2.6: Simple single-compartment model for tumor blood flow
In Zierler’s model, this fluid compartment has constant rates of blood flow at entrance and exit,
and also has constant total volume. At time t = 0, a finite quantity of indicator is impulsively
introduced at the input artery. Let m be the amount of indicator introduced into the compartment,
and let F be the constant rate of blood flow. The model assumes that all of the indicator will drain
from the compartment in a finite amount of time. Let c(t) be the concentration of indicator leaving
the compartment at time t. With these assumptions, the amount of blood leaving the compartment
in an infinitesimal amount of time is F · dt. The amount of indicator that leaves with this volume







It is useful to describe the fractional amount of indicator that leaves the compartment at time t





To solve for the total volume of fluid V passing through the compartment, the model defines
a infinitesimal unit of volume, dV , that contains the concentration of indicator exiting the com-
partment at time t + dt. The rate at which dV exits is described by F · h(t)dt. dV is equal to this
fractional rate times t (2.8). The total volume of blood is obtained by summing over all time (2.9).







0 t · h(t)dt is the mean value of t. This is better understood as the mean transit
time, t̄, or the average time that a small amount of indicator takes to drain from the compartment.





This model of fluid flow is based on several critical assumptions. In addition to constant blood
flow and volume of the fluid compartment, every indicator particle enters and exits the volume
only once. In a physiological context, there can be no recirculation of the fluid and indicator. This
model also assumes that h(t) is stationary: the distribution of indicator transit times remains time
invariant. Furthermore, h(t) is assumed to match the distribution of transit times of the blood. This
implies a complete homogeneous mixing of indicator and blood.
In reality, these assumptions are rarely satisfied. Effects from recirculation do appear in the
image following the initial arrival indicator. Also, the manner of injection and vessel structure
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affect the arrival of indicator [Zie62]. As the bolus of contrast agent flows through the body, it
passes into the heart and through the lungs before being arriving at the region of interest. Only
a fraction of the initial injection will circulate through the tumor. Instead of an impulsive arrival,
the concentration will gradually increase over a small span of time. However, the indicator-diluter
model provides the basis for more sophisticated models of perfusion.
Other tissue models use multiple compartments to describe the exchange of macromolecular
indicator particles. A two-compartment model, for example, may represent the vascular space
and leakage space, with the exchange of indicator concentrations driven by a simple two-way
transfer function [Dal98]. The vascular integrity is characterized by constants that correlate with
permeability parameters within the tumor.
2.1.8 Convection-Diffusion Model
The convection-diffusion model of perfusion extends the ideas of Zierler’s indicator-diluter model
with a more realistic physiological representation. Here, indicator particles move through the
tissue region with two transfer methods. Convection transfers indicator particles by fluid motion
through the vascular bed, and diffusion transfers indicator particles in both directions across blood
vessel membranes. The vasculature is then represented as a series of parallel convective tubes that
exchange the indicator with the extravascular space via diffusion. These tubes are so numerous
that from a macroscopic scale, they form an anisotropic continuum [KBKS04].
Consider the region Ω, consisting of N discrete convective tubes. Like the indicator-diluter
model, the flow in and out of Ω is temporally independent. The blood flow is also spatially con-
stant with respect to the boundaries of Ω. Let Ci be the concentration of indicator and Vi be the
volume of i-th compartment. The instantaneous rate of change of indicator quantity, ViC′i , is the
sum of contributions from other the remaining N − 1 compartments. The (i− 1) compartment
contributes indicator concentration to the i compartment via convection. Any other of the j ̸= i
compartments may exchange indicator concentration via diffusion. The constants ki and ki j de-
scribe the rate of the convection and diffusion, respectively. The rate of concentration change for a
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ki(Ci−Ci−1)





Figure 2.7: Convection-diffusion model of perfusion. Transfer constants ki describe convective
movement and coefficients ki j describe diffusive transfer of indicator.
single compartment is the sum of the convective contribution from the upstream compartment and
the sum of all diffusive exchange:
ViC′i = ki(Ci−1−Ci)+∑
j ̸=i
ki j(C j−Ci) (2.11)
By expanding terms, equation (2.11) can be written as a matrix equation (2.12). V is the
diagonal matrix of each compartment’s volume, diag{Vi}. C⃗ is the column vector of indicator
concentrations in each compartment, ⟨C1, . . . ,CN⟩T The matrix b is the diagonal matrix of con-
vective transfer constants, b = diag{ki}. Finally, the matrix A represents the remaining arithmetic
operations on the diffusive transfer constants, ki j. Under the assumptions of this model, the con-
vective exchange between each compartment in Ω is constant. Therefore, the quantity (Ci−Ci−1)
is simply the arterial input function, CAIF for all i.
VC′ = AC+bCAIF (2.12)
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The general solution of this equation gives an expression for the concentration of indicator as a
function of time (2.13). The initial concentration of indicator in the region Ω is zero at t = 0. This
creates an initial condition problem where substituting C(0) = 0 yields a particular solution (2.14).
The quantity eV
















This form relates the concentration over time as a convolution of the tissue kernel and the




CAIF(t) ·K(t− s)ds (2.16)
The divergence theorem is applied in this form to relate the properties of K(t) to volume, flow,
and mean time parameters. According to this theorem, the net flow through the region Ω is the


















The quantity |νT n⃗| denotes the magnitude of the fluid flow vector ν in the direction of normal
vector n⃗ at a point on the boundary of Ω. At initial time, the concentration of indicator in the
volume is zero. Therefore, the venous output of concentration is also zero. For t = 0, let CVOF(t) =
0. To illustrate the significance of the initial value of K(0), let CAIF(t) = δ(t), the Dirac delta
function. This step function represents the instantaneous arrival of the entire quantity of indicator.
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When CAIF(t) = δ(t) is substituted into equation (2.16), C(t) = K(t). Making these substitutions
to equation (2.17) and taking the limit t→ 0 yields an expression for the net volumetric flow:
F =
∫
νtn<0 F |νT n|
vol(Ω)
= K(0) (2.18)
This model assumes vol(Ω) remains constant and there is no diffusive exchange across the






Applying the central volume theorem (2.10), the mean-transit time, t̄ is expressed as the ratio







[KBKS04] provides a complete derivation of these parameters. Beyond the convection-diffusion
model, n-diffusive compartment distributed parameter models may improve estimates [KCS03]. In
addition to a series of convective tubes, multiple diffusive compartments are identified with indi-
vidual transfer coefficients. The number of compartments is chosen to account for the degree of
heterogeneity of tissues in the volume Ω.
2.1.9 Perfusion Recovery
However, given the nature of our data acquisition, we refrained from trying to obtain absolute
quantification of the flow, and volume, due to the complex set of influencing variables of patient
physiological parameters, and concentrated on developing the machine classification to perform di-
agnosis in the relative quantities, and operating primarily on the attributes of the residual function.
However, as an alternative to removing tissue by biopsy, medical imaging can reveal information
about the amount of new vasculature surrounding a tumor. A diagnostic protocol based on medical
21
imagery has yet to provide results that are as accurate as biopsy. Some existing techniques which
use MRI are significantly less accurate in comparison [HFE+94]. Clearly, signal enhancement-
time curves alone are unable to reliably differentiate levels of a tumor severity [FHSK+05].
Absolute perfusion in real units of mL/g/s is difficult to quantify for a number of reasons.
A known quantity of contrast agent injected into the bloodstream passes through multiple body
parts: the lungs and heart, for instance. These compartments “spread out” the concentration of
contrast agent before arriving at the tumor locus. Without knowing precisely how much contrast
agent is being delivered to the region-of-interest per unit time, the signal change in the image
cannot be related to an absolute quantity [Kis01]. In some cases, with model approximations and
specific imaging hardware, an approximate quantity of blood flow can be determined. The FAIRER
(Flow-sensitive Alternating Inversion Recovery with an Extra RF Pulse) scanning technique, for
example, can approximate the perfusion in lung tissue. Results of this experiment were slightly
overestimated due to a ROI selection that may have included pulmonary artery input [MCE00].
Measurement of the concentration of contrast agent as it enters the tumor volume, CAIF(t), is
not an easy task. In brain tissue, the superior saggital sinus (SSS) provides a convenient artery to
measure CAIF(t) as the bolus of contrast agent arrives. In breast tissue, however, there is not such
a distinct structure to measure this function. In these cases, the CAIF(t) is typically approximated
by applying a exemplary pharmacokinetic model for the particular contrast agent used [YLL+05].
Delayed arrival of the contrast agent due to dispersal introduces error in the perfusion estimate.
In these models, the arrival of contrast agent is represented with a step function, δ(t). Several
strategies attempt to reduce this effect [JHHMS04, WsK+03]. One approach to correct for this is
to introduce a time shift, tD into the convolution (2.21). A linear regression line is computed for
data points occurring before tD: the pre-contrast signal. A second regression line is fit to points
following tD, but before maximal signal enhancement. An optimal choice for tD maximizes the
difference between the slopes of these lines.
CT (t− tD) =
∫ t
0
K(t− s)CAIF(t− tD)ds (2.21)
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Perfusion estimation error may also result from stenosis, or narrowing of vessels from which
the arterial input function is measured. This produces additional delay and dispersion of the
contrast agent, such that the measured CAIF(t) is not the true input to the tumor voxels. Block-
circulant deconvolution may make the perfusion recovery process independent of dispersal and
delay [WsB+03].
Injection rate of the contrast agent also impacts perfusion results. For most image acquisition
protocols, a powered injector delivers the bolus at a rapid-constant rate to reduce dispersal effects.
Delivering the contrast agent at slower rates may improve perfusion estimates by increasing the
signal-to-noise ratio with a coarser temporal resolution [NDDT+03]. Simulation of a slow infu-
sion contrast injection suggests a SNR nearly 5 times greater than fast injection followed by high
resolution imaging.
Recirculation effects break the assumptions of the convection-diffusion model. The contrast
agent which has left the volume may be reintroduced and registered if the acquisition time is
sufficiently long. Instead of using a sampled value for CAIF(t), a gamma-variate curve is often
used to represent tracer dilution with recirculation effects [PAK+02].
Once the system identifies the tumor region, we can compute relative levels of perfusion in
the tumor classification. The signal enhancement is a convolution of the arterial input function
with the tissue response kernel. Commonly, experimental procedure calls for the application of a
pharmacokinetic model as the arterial input function. To further improve our perfusion estimates,
we will adjust the phase, amplitude, and dilation of the stock pharmacokinetic equation for use in
our deconvolution. We may also experiment with other pharmacokinetic equations if required.
The discussion of perfusion analysis results in the convolution equations that are solved com-
putationally and presented in Chapter 3. The goal of this research, however, is to develop a clas-
sification framework that can be trained to use this recovered perfusion information to generate
a diagnosis of disease-free, benign, or malignant ROIs given a signal enhancement series and a
controlled image acquisition protocol. Tools for this classification are discussed next.
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2.1.10 Methods for Deconvolution
The “undoing” of a convolution operation is deconvolution. In the general context of signal pro-
cessing, deconvolution may be used to remove the effects of noise to recover the original function.
In the context of perfusion analysis, it is the properties of the kernel more than the properties of the
input function that describe the exchange behavior between the vasculature and the extravascular
space. There are numerous methods to perform deconvolution. Some methods are more computa-
tionally efficient, while other may provide more stable solutions in low signal-to-noise conditions.
What is represented in K(t) also includes noise effects. Increased spatial resolution or temporal
resolution worsens these effects. Even though the data acquisition in this research focuses on T1-
weighted processes, where temporal resolution is low, the contribution of noise in the experimental
method deserves some inspection and treatment.
Fourier transform of a signal reveals its spectral components. A signal can be represented as a
summation of trigonometric basis functions. In a stationary signal, the spectral components remain











The Fourier transform is described by equation (2.22), where ω is in radians. The inverse
Fourier transformation is equation (2.23). When applied to a convolution operation, the Fourier
transform changes it to multiplication. Let the Fourier transformation of a function f be F ( f ).
Then:
F ( f ∗g) = F ( f ) ·F (g) (2.24)
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equation (2.24) is the convolution theorem. Deconvolution can then be accomplished by divid-
ing both sides of the equation by the transformed input function. However, if the coefficients are
near zero, then the solutions may be very unstable.
Another technique is deconvolution using the Moore-Penrose pseudoinverse. When the con-
tinuous convolution equation is discretized, it can be written as a matrix equation, Ax = b. Here,
x represents the original function being recovered in the deconvolution. A unique solution for x
may not exist, but the pseudoinverse of A can be used to determine a unique, least-squares fit.
Mechanically, the convolution matrix cannot be inverted, due to the row rank of A being greater
than is column rank. A is not a square matrix. Algebraically, there are more linear equations in this
system than variables. The Moore-Penrose pseudoinverse can be derived as follows.
Ax̂ = b
⇒ AT Ax̂ = AT b
⇒ (AT A)−1AT Ax̂ = (AT A)−1AT b
⇒ x̂ = (AT A)−1AT b (2.25)
Singular value decomposition can be used to compute the pseudoinverse as well. The singular
value decomposition of an ill-conditioned matrix can be useful in computing better solutions. The
singular value decomposition of a matrix A is written as the as a matrix product UΣV T . Σ is the
n× n diagonal matrix of the eigenvectors of A ordered in descending magnitude. U and V T are
each orthogonal matrices containing the left-singular and right-singular vectors of A, respectively.
25
A =UΣV T =

| |

















Observe that the rows and columns of U , Σ, and V form an orthonormal inverse of a product
of orthonormal matrices and is the reversed product of their transposes [Lea04]. Substituting the
matrix decomposition into (2.25), the least-squares solution is (2.27).
Ax̂ = b
⇒ (UΣV T )x̂ = b
⇒ (UΣV T )T (UΣV T )x̂ = (UΣV T )T b
⇒ x̂ =
(
(UΣV T )T (UΣV T )
)−1
(UΣV T )T b
⇒ x̂ = V Σ−1UT b (2.27)
Written in this form, the system can be easily adjusted to mitigate noise effects to improve
the stability of solutions [KWCL04]. The eigenvectors of A, σ0, . . . ,σn are ordered in decreasing
magnitude. The magnitude of the condition number can be controlled by choosing some k of
the eigenvectors, such that σ0/σk is acceptably small. This method of truncated singular value
decomposition (TSVD) eliminates the smallest magnitude eigenvectors, which likely correspond
to noise effects.
Choosing the optimal number of eigenvalues to retain can remove noise and preserve signal
information. Koh, et.al. developed strategies to choose an optimal truncation value by observing
properties of the solution kernel [KWCL04]. Koh uses a Picard plot of the solution norm, ∥x∥
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versus the residual, ∥x−Ab∥. Using a piecewise regression approach, the optimal truncation value
is the point of greatest curvature in the plot.
Maximum likelihood (ML) deconvolution is another approach used to recover perfusion pa-
rameters. Fitzgerald develops an iterative method for a non-linear least squares algorithm [FON08].
The algorithm uses a grid search to optimize parameters for the reconstruction of the residue func-
tion. In cases of low signal-to-noise, this algorithm demonstrates better perfusion parameter esti-
mation for simulated MRI data.
In the extreme case where only the output function is available, and neither function f or g
is known, blind deconvolution techniques may be able produce a result. In blind deconvolution, a
general constraint on either f or g is used to iteratively generate estimates of both operands [AD88].
For example, in c = f ∗ g it may be known a priori that both f and g are non-negative. Blind
deconvolution begins with an initial estimate for f . The function g is obtained by a conventional
deconvolution method, such as Fourier division. The known constraints for g are then applied to
this estimate. Any negative values are replaced with zero. A new estimation for f is computed, and
the process is repeated until two non-negative functions with a convolution of c are determined.
As the iterations proceed, computational problems may arise as matrices formed by f and g may
become ill-posed for deconvolution.
Generate estimate for f
Recover f by deconvolution
Recover g by deconvolution
Apply constraints for f Apply constraints for g
Figure 2.8: Generalized blind deconvolution
27
2.2 Machine Learning Algorithms in Diagnosis
Having reviewed the relevant perfusion models, the next step in constructing a computer-aided di-
agnosis framework is selecting a set of machine learning algorithms. Machine learning algorithms,
given a training data set, can make objective predictions for a set of new test cases. First, the med-
ical data must be conditioned into a representation that the learning algorithm can use. Time series
data, an image raster, or a combination of both can be formulated into a feature vector of arbitrary
length. There are several examples of medical data that can be used for learning. With electro-
cardiogram data, a time series can be “learned” for detecting ischaemic heart disease. [KKG+99]
applied several different algorithms including back-propagation neural networks, a naive Bayes
classifier, and a K-nearest neighbor algorithm. Breast ultrasound represented in digital imagery
has been studied for the purpose of characterizing microcalcifications [CWMC03]. In this study,
windowed subimages where generated from the original ultrasound image, and trained in a sup-
port vector machine as a form of texture analysis. A similar approach for digital mammograms
was studied in [ENYW+02].
There is no shortage of machine learning algorithms. Artificial neural networks (ANN) are
a popular choice for concept learning and are based on their biological counterpart: connected
neurons in the human brain. The network is a set of interconnected neurons, with an input layer,
output layer, and hidden layer. A pattern is applied to the input layer, and an output pattern is
generated through the weights and interconnections of the hidden layer(s).
Twellmann, et. al., have developed a back-propagation neural network for signal enhancement
data as input that generates a tissue classification [TLN05]. Their classification framework is
designed as a model-free tissue classification model versus model-based methods, such as the 3TP
method. The classifier developed in their paper is called the Adaptive Tissue Classification Neural
Network (ATCNN), which compared its accuracy to that of the 3TP method. The methodology
developed in Chapter 3 subsumes this by considering both the signal enhancement data and the
characteristics of perfusion recovery, to improve classification accuracy. Hoyt, et. al., also use
a neural network approach for analyzing contrast-enhanced ultrasound imagery [HWU+10]. The
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machine learning method was used to evaluate the effect of an anti-angiogenic drug, Bevacimuzab,
on breast cancer in mice.
2.2.1 Support Vector Machine Classification
The support vector machine approach to data classification has demonstrated excellent perfor-
mance in the realm of two-class pattern recognition in a feature space of arbitrary dimensions.
The support vector machine is based on statistical learning theory, which has found application
in a number of application domains: optical character recognition, face matching, and text clas-
sification. In the medical realm, it has been applied largely to ultrasound imagery and texture-
based classification [CWMC03, CWM+03, KP03, WSM93, LKP+08b, KT10]. In this section, we
present a basic overview of the Support Vector Machine approach, where thorough treatments of
the statistical learning foundations can be found in [Bur98, MM08].
A set of vectors xi ∈ Rn, i = 0 . . . l each have a classification, yi ∈ −1,1, where −1,1 represent
the two classes in consideration. As with any learning algorithm, a subset of these vectors and
their respective classes (xi,yi) are chosen as a training set. The support vector machine determines
a mapping xi→ f (xi,α), where α are the learned parameters of the mapping. The analog for α in
a back propagation neural-network classifier would be the node weights at each perceptron. The
SVM can then be tested using the remaining examples.
For a given set of parameters α, the average error rate on the training set, or the empirical risk







|yi− f (xi,α)| (2.28)








The variable η denotes the probability of the loss function taking the value 0 correctly trained,
or 1−η incorrectly trained. The variable h is a non-negative integer called the Vapnik-Chervonenkis
(VC) dimension. The VC dimension represents the “capacity” of the learned machine, f (x,α). The
capacity of a trained classifier is a measure of how it generalized beyond the training data set. A
classifier with too high a capacity will over fit the training data, and fail to generalize to new testing
vectors. Conversely, a classifier with too low a capacity fails to properly discriminate new testing
vectors.
Assuming the training set is independently drawn, and individually separated, the SVM algo-
rithm proceeds to find a set of partitioning hyperplanes that maximize the margin of separation
between the classes being sought (Figure 2.9).
Support Vectors
Figure 2.9: Support Vector Machine maximizes the margin of separation between feature classes
The determination of the separating function(s), are obtained by numerical optimization of
these error bounds, even though faster greedy algorithms have been developed to converge faster
and more stably [VM03]. In this research, we have selected the sequential minimal optimization for
quadratic decomposition implemented in libsvm [CL01] and utilized by the PyML code [BH07].
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The general applicability of the SVM method has popularized its use in the medical domain for
screening and diagnosis. The most common application is for texture or morphology of suspicious
image features. In [ENYW+02], SVM is applied to ultrasound imagery to detect microcalcifica-
tions. The feature vectors, xi, in this are M×M windows surrounding each input pixel.
2.2.2 K-Means Cluster Analysis
While not a learning method, the k-means clustering algorithm is often employed in image seg-
mentation. The algorithm divides vectors in a multi-dimensional feature space into k-fixed groups
in an attempt to minimize the intercluster variance. When used for image segmentation, each pixel
becomes a feature vector with coordinates and the pixel value I(x,y) as the feature vector compo-
nents: ⟨x,y, I(x,y)⟩. The k-clusters are randomly initialized to members in the feature space. The
algorithm iteratively reassigns the cluster groups by closest cluster centroid. Each cluster centroid
is recomputed and the recombination is run again. The algorithm converges and halts when no
cluster-reassignments occur (Algorithm 2).
Algorithm 2 K-Means Algorithm
Given a set of feature vectors, V , and k initial clusters,
Assign each vector to a random cluster.
repeat
Let ClustersChanged = false
for all v ∈V do
for all C j ̸= memberO f (v) do
if distance(v,centroid(C j))< distance(v,centroid(memberO f (v))) then
Assign v to C j




until ClustersChanged = false
The algorithm is implemented using the Euclidean distance measure. Many improvements can
be made to the direct K-means method. A more efficient implementation using KD-Trees can be
used to improve the execution time [ARS98]. The number of clusters, k, is selected arbitrarily by
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the user, and increased or decreased to improve the “fit” of clusters to the vector space. The initial
assignment of the clusters to vectors in the set may also affect the segmentation result. Methods
have been developed for refining the selection of k and the cluster initialization [BF98]. For image
segmentation, the result can be evaluated in terms of differentiation and connectivity. The quality









K-means segmentation has been applied to medical image segmentation of the MR and X-ray
images of the brain and other tissues [SWDH02, PP99, PXP00]. Chapter 3 describes how K-means
clustering is used as a segmentation aid for identifying training data in the MR imagery.
Subspace clustering and projected clustering are other techniques that may be relevant. With
higher-dimensional, manually composed feature vectors, the meaning of a distance measure be-
comes less intuitive. For instance, a feature vector that contains a spatial coordinate, pixel intensi-
ties over time, and other meta-information might cluster very strongly spatially, but fail to cluster
on intensity. Subspace clustering is one way to discover clusters on arbitrary subspaces with the n
dimensions of the feature vector. In this way, a feature vector may be part of 0 or more subspace
clusters. This is may discover clusters on seemingly unrelated components of the vector. An ex-
tension of subspace clustering is projected clustering, where each vector is assigned to one, and
only one cluster which may exist on a subspace of the vector space [AWY+99].
We employ some of these extensions to the classification framework during segmentation for
training sets to improve the training data in our research.
In the next chapter, we formulate a classification framework that exploits both the spatial and
temporal nature of the medical data, and employ these learning algorithms to evaluate their efficacy





The 29 MRI breast studies with the Volume Imaging for BReast AssessmeNT (VIBRANT) acqui-
sition protocol were retrospectively examined in this research with all patient identifiers eliminated.
The dynamics image series began with a full resolution, pre-contrast T1-weighted acquisition. The
contrast agent, 20cc of gadolinium with saline, was administered by powered injection. The time
series consisted of five post-contrast imaging sequences spaced 90 seconds apart. Each acquisition
produced a three-dimensional volume with a spatial resolution of 512 pixels left-to-right and 512
pixels anterior to posterior. The Z-axis resolution of each data set varied from 84 to 156 pixels
from superior-to-inferior. The MRI sequence parameters for the contrast enhanced series were
T R = 5.2− 5.7, T E = 2.1, and T I = 17. Each pixel had 8-bit grayscale intensity values from
0−255. Each data set included other non-contrast enhanced images with MRI parameters set for
different tissue contrasts. The pathology for each data set was retrieved and correlated to lesions in
the images. Additional X-ray and ultrasound studies also helped correlate the pathology analysis
to a ground-truth answer.
During initial examination of the cases, the GE CADStream software package visualized en-
hancement data in the VIBRANT series. CADStream offered several useful views of the imagery
for enhancement analysis. The default 3-panel view in CADStream showed axial, saggital, and
coronal projections. A Dynamics overlay could be toggled, showing enhancement areas based on
the 3-Time Points method (3TP), though the colorations were non-standard. Yellow, blue, and
red were used instead of the red, green, and blue color scheme described in the typical method.
When compared to a manually implemented 3TP result, CADStream also appears to be filtering
single-points of enhancement, possibly with a median or averaging post-processing filter.
In CADStream, the Curves dialog was used to graph the enhancement series at a mouse-
selected point. Here, the first and second enhancements are displayed as percent change. An-
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other Surface dialog showed a three dimensional surface generated at a mouse-selected feature.
It is unknown what criteria was used to segment and generate this surface, though the segmenta-
tion roughly included areas of similar enhancement. The 3D surface view computed the selected
feature’s dimension and volume, as well as an ellipsoidal buffer region for a surgical biopsy esti-
mation.
Within CADStream, there was no way to access the enhancement information in a computable
form. Also, to ensure that there were no post-processing effects from CADStream, the images
were exported into DICOM format. The imagery was saved in separate folders for each study. The
DICOM format contained imaging parameters in the metadata sections to identify the time, spatial
orientation, and dimension. LSU Health Science technicians aided in the anonymization of each
study such that only image data and a generic identifier remain prior to analysis (e.g., Data Set 01,
Data Set 02, etc.).
OsiriX was a medical imaging application that supports the DICOM format [RSR04]. OsiriX
could generate 2 and 3 dimensional views, maximum-intensity projections and surface renderings.
Each anonymized DICOM directory was imported into OsiriX as a separate study. OsiriX failed to
group the images with respect to time. However, OsiriX did support exporting the DICOM images
to an alternate image format.
In order to work directly with the data, the DICOM had to be exported into a binary format that
was both lossless and conveniently indexed. Uncompressed TIFF served as an intermediate format
to extract the DICOM images. The export was performed with OsiriX on a dual-quad core Apple
MacPro 3GHz, with 4GB of system memory. After each axial slice was converted to a 512×512
TIFF image, an optimal storage format for the images was constructed. Each data set was stacked
and reordered such that the time series for a single voxel was stored contiguously (Figure 3.1). A
Python script collected the time series at each voxel, iterating over each image in row-major order.
Each slice was visited in an inferior-to-superior order. The final binary files for computation were
referred to as stacked enhancement volumes.
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Figure 3.1: Contiguous-time stacked enhancement files
A Python class library was written to interact with these stacked enhancement volumes intu-
itively and efficient for computation. With the Python NumPy libraries, these volume files could
be memory-mapped and treated as a 4-dimensional array, (x,y,z, t). The library access functions
ignored any zero-valued time series as a background pixel, to eliminate unnecessary processing
operations.
3.2 Computation
3.2.1 3-Time Points Implementation
To produce a baseline result, the 3TP algorithm was implemented in Python as defined in section
2.1.6. Times t0, t1, and t3 were chosen to be the pre-contrast, maximum enhancement, and post-
contrast times, respectively. For each time series, the color category was computed, and the 8-bit
intensity was assigned based on the algorithm. The algorithm was also written in Python and the
Python Imaging Libraries (PIL) provided routines to compose the images in memory and write
them to disk.
The output according to the algorithm produced pixels too dark to distinguish visually. As a
visual aid, the intensity for each pixel was brightened according to the mapping function, x′ =
f (x) = ⌊255 ·
√
x/255⌋, where x is the red, green, or blue intensity in the range [0,255] from
the 3TP algorithm. The behavior of this function boosts the lower range of the brightness values
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floor(255 * sqrt(x / 255))
Figure 3.2: Intensity brightening applied to 3TP output
The output was overlaid on the original pre-contrast image for reference, and each slice was
output in 32-bit PNG for visualization. Several strategies were employed to reduce the presence of
single pixel outliers and more closely match the output of the CADStream Dynamics View. A 3×3
median filter was applied to the output prior to compositing. This filter was applied independently
to each channel (red, green, and blue) then to all channels simultaneously. Larger median filters,
5×5 and 7×7, were also attempted on representative data sets.
A second strategy to reduce outliers was to select a threshold for the initial enhancement inter-
val. Below that threshold in the range [0,255], the 3TP value was set to zero. In this case, only the
pixels with a high enough initial enhancement period would remain. Finally, these noise reduction
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methods were combined to both remove single-pixel outliers and truncate pixels with low initial
enhancement values.
The results of the implemented 3TP were compared against the output from CADStream and
qualitative judgments were made. It was not possible to quantify the CADStream 3TP results as
the data in the Dynamics view could not be exported. The closest resultant match was used as a
baseline result against the classification result described next.
3.2.2 Matrix Construction
In the equation C(t) = CAIF(t) ∗K(t), the perfusion is characterized by the tissue kernel, K(t).
Properties of this function such as maximum value, area-under-curve, and initial value can be
related to perfusion quantities as described by equations (2.18), (2.19), and (2.20). To solve for
K(t) using the VIBRANT imagery, a discrete convolution equation was constructed and solved
with matrix deconvolution methods.
Let C(t), CAIF(t), and K(t) be functions of the discrete time points t0, t1, · · · , tn−1. Convolution
is performed by first using the elements of one of the operands in descending order. The operands
are overlaid such that the first elements overlap. The corresponding elements are multiplied and
summed to produce one value of the convolved signal. The reversed operand is shifted to the right
by one step, and the corresponding elements are again multiplied and summed. This operation
can be represented by a matrix equation Ax = b, where A is a Toeplitz matrix created by shifting
CAIF(t) to the right for each descending row. The elements of A, x, and b are defined in terms of




CAIF(ti− j), 0≤ j ≤ i
0, i < j
xi = K(ti)
bi = C(ti)
i = 0, · · · ,n−1 (3.1)
The tissue concentration function C(t) is the enhancement time series from the imagery at each
pixel. Note that the matrix b has 2n− 1 elements, resulting from the dimensions of the matrix
multiplication product, where a 2n− 1× n matrix multiplied by a n× 1 matrix yields gives a
2n−1×1 matrix. To achieve the desired length, we interpolated additional points between actual
points as necessary. The justification for increasing the number of the observed points is due to
the coarse temporal resolution of the VIBRANT acquisition sequence. As a future improvement,
different interpolation methods might be employed to introduce smoothness, such as a cubic spline
polynomial fit. Equation (3.2) illustrates this matrix construction.
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3.2.3 Input Function Selection
One very important detail is to define the selection of the input function CAIF(t). Two principle
methods for input function selection are used based on physiological appropriateness [STCD04].
In some parts of the body, the tissue pixels are adjacent to a large artery. Here, the enhancement
due to the contrast passage is clearly seen. In cerebral perfusion recovery, for example, the superior
saggital sinus is located as shown on Figure 3.3. The circled feature in the middle image is at the
maximum enhancement point and can be sampled.
Figure 3.3: Superior saggital sinus in cerebral perfusion
However, the vasculature in the breast tissue does not usually present such a convenient fea-
ture. Though blood vessels were visible in the VIBRANT imagery, the spatial resolution of the
structure was typically not large enough to guarantee that there was no contribution from surround-
ing tissue enhancement. In this case, a pharmacokinetic model that approximates the typical bolus
arrival pattern was used. A gamma distribution has shown to correlate well with the measured
AIFs [WsB+03]. In equation (3.3), CAIF(t) was approximated by the gamma distribution with




0, t < t0
C0(t− t0)αe(t−t0)/β, t > t0
(3.3)
The parameters α and β control the shape and scale of the gamma distribution. Typical values
used with a pharmacokinetic system are α = 3.0, and β = 1.5. This equation was sampled at time
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Figure 3.4: Gamma variate function for various values of α, β
Both methods for CAIF(t) selection were attempted. For a sampled CAIF(t) a representative
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Figure 3.5: CAIF(t) sampled from several blood vessels
averaged. Figure 3.5 shows several enhancement series from manually located blood vessels, and
their averaged curve.
3.2.4 Discrete Deconvolution
This system defined 2n× 1 equations in n variables. The solution of this system was found by
several methods of deconvolution. For both methods of input function selection, three forms of
deconvolution were applied: Moore-Penrose pseudoinversion, singular-value decomposition, and
blind deconvolution. The kernels from the deconvolution of from each method were compared, as
well as how each method affected the classification results.
The Python language and its accompanying scientific library SciPy were selected as the com-
putational platform because:
1. The file-to-memory mapping capabilities allow convenient abstractions to be written to han-
dle the stacked enhancement volumes.
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2. The SciPy library provided a set of matrix structures in a “Matlab-like” syntax.
3. Parallel runs were also easily distributable, even though Python does not provide true processor-
level parallelism within a single execution instance.
4. General image input, manipulation, and output is an important feature of the language and
libraries.
5. Machine learning toolkits such as PyML provided the K-nearest neighbor and SVM for the
classification stage.
The perfusion recovery code operated directly on the time series of the stacked enhancement
volumes. Each volume was loaded into memory, and mapped into a 4-dimensional array. Iterating
over each location, the 8-bit integer series was deconvolved into a 32-bit double-precision repre-
sentation and stored in another binary file, referred to as a stacked kernel volume. The stacked
kernel volume was arranged with the same indexing as the stacked enhancement volume.
Several optimizations improved the computational processing time for each volume. Each
time series can be deconvolved independently of any other point in the volume. There were no
data dependencies in the processing loop and therefore the operation could be “completely” paral-
lelized. Utilizing up to eight cores on the MacPro workstation, each stacked enhancement volume
was divided into a length/N segment for processing. Each segment was sent to a separate core
to deconvolve. Then all core results were merged at completion. Due to the global Python inter-
preter lock, a multi-process implementation was selected versus a multi-threaded implementation.
The processing was computationally bound, not communications bound, since the entire stacked
volume file could be contained in real memory.
Additionally, the blind deconvolution was applied iteratively to estimate K(t) and CAIF(t).
CAIF(t) was initialized as a gamma distribution with α = 3.0 and β = 1.5. CAIF(t) and K(t)
were designed to be non-negative functions. Because of this requirement, any negative values




Training data sets were generated for a pre-selected subset of the images using the original MRI
sets, their pathology information, and any other information available. From the disease-positive
data sets, a single axial slice image was selected if it contained a pathology-confirmed tumor. From
the disease-negative cases, a slice containing an enhancing feature, such as a cyst, was selected if
present. Otherwise, an axial slice passing through the nipple was chosen.
In the selected disease-positive images, the tumor pixels needed to be distinguished from the
non-tumor pixels with a tumor mask. This tumor mask was generated manually at first, and then
later with the aid of a segmentation algorithm. A program was created to assist both methods
of generating the tumor mask, PerfusionView. PerfusionView was written using C++ and open
source Qt libraries its the graphical interface and image handling. The software supported loading
the stacked enhancement volume files and displaying axial, saggital, and coronal projections of the
three dimensional volume presented on Figure 3.6.
PerfusionView allowed panning through the volume on each axis, selecting a specific time
point, or centering on a mouse-selected point in all three views. 3TP results could be toggled
as an overlay to the imagery. PerfusionView functioned in three modes: inspection, mark-up, and
classification. In inspection mode, the time series for the point underneath the cursor was shown on
a graph, along with its 3TP classification. This capability is very similar to the CADStream Curves
display. In mark-up mode, the operator could use a variable size drawing tool to paint the tumor
mask onto the image. This mask could be saved as a 1-bit image to be used in the classification
training phase. Having generated a bitmask for a selected axial slice, the classification mode
launched the training and testing phases of the classification.
3.3.2 Segmentation-Aided Marking
The manual marking facility in PerfusionView was one method for indicating disease-positive
pixels in the imagery. Correlating the study pathology with the imagery and the radiologist report
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Figure 3.6: PerfusionView with a stacked enhancement volume
provides a rough location and morphological description of a lesion. Radiologist descriptions were
defined in “clock face” position. From a coronal view the nipple was the clock center, and the tumor
was reported in terms of clock axes, one through twelve o’clock. Tumors located behind the nipple,
or retroareolar tumors, may not have had a clock face position. These rough descriptors, aided in
locating obvious tumors. However, there was always the possibility of a significant marking error
due to poor boundary resolution in the original image. An improved method for assisting in the
marking of the training sets was devised using the previously described K-means clustering.
For each training data set, each kernel function in the stacked kernel volume was added as an
element in the population to be clustered. The algorithm was initialized to k = 7 random clusters
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as described in section 2.2.2. The selection of the number of clusters was determined through
experimentation. This choice of number of clusters provided the best balance between intercluster
variance while not over-fitting the data. The Euclidean distance served as the metric in the K-means
algorithm:
P = (p1, p2, . . . , pn)







The clustering algorithm was implemented in C++, also using open source Qt classes for image
input and output. From PerfusionView, the deconvolution routine was first executed for an entire
stacked image volume. The clustering function was executed next with a selectable number of
clusters. Upon completion, the clustering program generated an output image per axial slice in
the same image resolution as the original VIBRANT images. A representative feature vector was
generated for each cluster by averaging all the final cluster members. To visualize, each cluster
feature vector was ordered by maximum component value, and a color map was applied for each
cluster.
This image is reviewed to include or exclude groups of pixels that belonged to the same cluster
and were spatially adjacent. This alternate method of marking tumor pixels was expected to have
an impact on both training and testing the classifiers used in the final stage shown on Figure 3.9.
Both the segmentation-assisted marking method and the completely manual method were used to
generate testing data for the classifier training and testing phase. The effects on accuracy in the
classification phase were compared with receiver operating characteristic (ROC) analysis .
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Figure 3.7: K-Means cluster result
3.3.3 Training and Testing
The tumor mask and the corresponding data points generated in both testing and training sets was
used for classification. Using PerfusionView, the tumor mask was combined with the stacked
kernel volume. An index appended to the end of the tumor mask file name was used to reference
the axial slice marked for classification. The 1-bit mask had a value of 1 for a pixel marked
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Figure 3.8: Cluster result shown with tumor clusters isolated
disease-positive and 0 for a pixel marked disease-negative. Pixels in the stacked volume that have
a zero-valued kernel function were excluded from both the training and testing sets.
PerfusionView generated a feature vector for each point that does not have a zero-valued kernel
function. The values of K(t) and the derived quantities from the central volume theorem were
added to this feature vector. Because the relative flow was the same as the kernel function at t = 0,
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Figure 3.9: Selected clusters added to tumor mask
it was omitted from the feature vector. Total relative blood volume computed from the area under
curve of the kernel function was included in the feature vector. The trapezoidal rule was used to
compute the area-under the curve. The mean particle transit time was the ratio of volume to flow.
The flow is divided by the initial value, K(0), and incorporated in the feature vector.
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In addition to the estimated relative perfusion parameters, the feature vector includes other
properties of the kernel. The first and second order forward differences characterize the shape of
the kernel. The rates of change reflected in these two functions present characteristics that are
independent of individual signal or kernel values.
k′i = K(i+1)−K(n) : i = 0,1, . . . ,max−1 (3.5)
k′′i = K(i+1)−2K(i)+K(i−1) : i = 1,2, . . . ,max−1 (3.6)
























Different training set sizes were chosen for the SVM initialization phase. The training set
size effects the accuracy, specificity, and sensitivity of all of the classifiers tested. In the trails,
percentages of the pixels in axial slices ranged from 10% to 100% in 10% increments. In each trial,
with a percentage of training data to be used, the perfusion software randomly selected examples
from the population and wrote them to an external file. Each example contained the user-marked
classification, pixel coordinate, a data set index, and the fixed-length feature vector. A Python
program loaded the training examples file for each trial. The program then instantiated a new
classifier using the SVM implementation from the PyML machine learning library. The examples
were passed to the SVM for training. The program wrote the trained SVM in an external file.
The classification trials were organized such that examples were included from the same stacked
volume as well as from other stacked volumes. The first set of classification trials chose elements
from the axial slice where the SVM training examples were selected. The Python code chose clas-
sification examples that were mutually exclusive with the original training set. The second set of
classification trials used examples from other axial slices in the same volume. The alternate slices
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were chosen at regularly-spaced intervals and marked manually and with segmentation assistance.
The third set of trials used an SVM model and classified examples from other stacked volumes.
3.3.4 Challenges
Current models for the concentration behavior originated from indicator-diluter theories of Zierler,
et.al. [Zie62, Zie63]. These theories made the following assumptions:
1. Every particle of fluid entering a voxel compartment leaves in a finite time.
2. There were no effects due to recirculation.
3. The volume of the fluid compartment remained constant.
4. The flow rate through the fluid compartment was constant.
Most of these assumptions were not realistic in the actual physiology. The circulatory system
is closed, so recirculation effects were present [KBKS04]. Also, these tissues were non-rigid, and
tumor boundaries were not easily defined. Finally the circulatory system did not maintain constant
flow; rather, the heart pumps blood through the tissue in a periodic fashion.
These assumptions about the contrast agent bolus as it travels through the body could have
created significant errors in the estimation of flow rate per unit tissue volume. Also, the manner
in which the imagery was obtained introduced variable amounts of noise in the observed data.
Examining the condition number of the discretized convolution matrix showed the deconvolution
solution to be possibly noise-sensitive.
Calamante [CGC02] discussed making assumptions to the arterial input function, CAIF(t) in
computing blood flow. Specifically, any deviation of actual bolus arrival behavior from the esti-
mated model affected the amount of perfusion computed. From the injection site into a vein, the
bolus of contrast agent had to travel to and from the heart, through the lungs, back into the heart,
and then distributed into the breast. Such a path will likely bias the shape of the arterial input
function. Adjustments to the parameters of the gamma variate function were made to compensate





The experiment consisted of four phases:
1. ground truth specification,
2. creation of controlled results with 3TP,
3. recovery of perfusion parameters by deconvolution,
4. training and of testing of perfusion feature vectors.
Prior to the experiment, the anonymized MRI data was reformatted for efficient access as
described in Chapter 3. Both the radiology report and pathology report gave some information for
locating the tumor in each study. A custom software tool, PerfusionView, provided visualization
and creation tools for manual tracing of each tumor mask. An assisted tracing method was also
used to refine the mask creation. The K-means clustering algorithm was run on the prepared data
for different numbers of clusters. Images of the clustering results were used to select the optimum
number of clusters for the algorithm. The cluster results were used to refine the boundary shape
of each tumor mask. Both methods of specifying ground truth were compared in the classification
phase of the experiment.
In the second phase of the experiment, the 3-Time Points (3TP) method was run on the MRI
data. Different time points were selected in each run until a satisfactory result was produced. Image
post-processing methods were tested on the 3TP results to approximate the results of the default
radiologist tool, CAD Stream. The performance of the subsequent classification were compared
with these results as an experimental control.
The third phase of the experiment investigated different methods for perfusion recovery. This
phase of the experiment explored three different ways to select the arterial input function. Not all
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methods yielded usable results. Usable perfusion results were carried forward to the fourth phase
of the experiment.
In the final phase of the experiment, different feature vector constructions were tested in a
support vector machine classifier. The feature vectors contained elements from the unmodified
experimental data as well as derived elements from the recovered perfusion data. The performance
of each feature vector construction was evaluated using 10-fold stratified cross validation and com-
pared to the 3TP results when used as a classification method.
4.2 Data Preparation
The twenty-nine radiological studies were initially identified for use in this research. Each study
was a complete image set of MRI scan types, including contrast-enhanced MRI time series. Two
studies were duplicates of patients for pre- and post-mastectomy comparison. The two post-
mastectomy studies were discarded. These twenty-nine studies represented twenty-seven indi-
vidual patients imaged with the VIBRANT protocol. Fifteen of the studies were positive for ductal
carcinoma and four of the studies were negative for ductal carcinoma.
In the eight remaining studies, the pathology was unavailable or incomplete, and hence were
removed from the pool. Only seven of the fifteen studies that were positive for ductal carcinoma
had one main tumor with a well-defined boundary. These studies were selected as training data to
reduce manual segmentation error. The remaining eight ductal carcinoma studies either lacked a
single, well-defined tumor boundary, or had multiple foci that would require a prohibitive amount
of effort to manually mark every tumor. Appendix 5.6 presents a complete list of all studies along
with a non-personally identifying data set number.
In preparation for analysis, all of the enhancement data were extracted into the time series-
volume format previously described. The following analysis operated on a single axial slice con-
taining the lesion’s largest cross-section. For the disease-negative studies, an axial slice through
the nipple center line was selected. Each axial slice was visualized with PerfusionView, using the
multiple-view windows to locate the enhancement behavior.
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In addition to isolating the axial slice in each study, the coronal plane that partitioned the breast
tissue from the chest was recorded. Though there are automated algorithms for determining this
plane, PerfusionView was used to manually inspect each study and isolate the breast tissue anterior
of the sternum.
Figure 4.2 shows a single axial image from each disease-positive study. The white bounding
box identifies the location of the tumor in each study; these are drawn manually. The brightness
level of these images were increased for improved illustration and do not indicate the intensities of
the 16-bit raw signal. Signal intensity within the DICOM image is expressed in Hounsfield units
(HU). Average brightness within each lesion was 1213 HU with a standard deviation of σ = 443
HU. The lesion texture varies between each study. The tumors in studies D15 and D16 have a
smoother appearance, while D1, D11, and D12 have a mottled appearance. The number of pixels
that belong to each lesion varied from 400 to 5039 pixels. The average lesion pixel count was 1737
pixels. Figure 4.3 shows each tumor area-of-interest in greater detail.
Figure 4.1 shows an axial image from the four disease-negative studies. In some of these
images, there are lesions that have been identified as non-cancerous masses, such as cysts. The
brightness of these images has also been adjusted for better illustration, and do not reflect the
brightness in the raw data. In Study D3, the left breast has a small feature that shows enhancement,
but with relatively few other landmarks in the breast. Study D14 has a fundamentally different
appearance in both breasts, with a higher initial enhancement value.
4.3 Specification of Ground Truth
The radiologist notes on the tumor morphology and the pathology report aided in establishing the
ground truth for each study. The radiologist report only described general location (left or right
breast, clock face position) and qualitative morphology. The pathology findings only described
presence or absence of cancer by tissue biopsy. Subsequently, the tumor in each study needed to
be traced with a manually drawn mask. A pixel was “cancer-positive” if it intersected this mask.
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(a) Study D3 (b) Study D4
(c) Study D14 (d) Study D27
Figure 4.1: Disease-negative studies, pre-enhancement axial imagery
Conversely, a pixel was “cancer-free” if the mask excluded it. Figure 4.4 shows the drawn tumor
masks.
This method of marking “cancer-positive” pixels depended upon the precision of the mask-
drawing tools. Therefore, a second method of specifying training data used a cluster-assisted
segmentation method.
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(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.2: Disease-positive studies, pre-enhancement axial imagery
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(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.3: Disease-positive studies, cropped to AOI
56
(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.4: Manually-drawn tumor masks are in red
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Each pixel time-series C(t) was constructed as a 5-element feature vector. The pixels from
each study were separately clustered with a K-means clustering algorithm. Through sequential
search, K = 7 was found to generate enough distinct feature classes. Each feature class was sorted
by maximum element value and assigned a color in a green-to-yellow-to-red color palette to create
the images presented on Figure 4.5.
Note that this was not a classification step, but a segmentation aid that was exploited in the
classifier training later in the dissertation. The pixels in the region did not always possess the
maximum C(t) value as shown in study D16. The clustering results were used to select regions
that corresponded to the tumor area in the disease-positive studies. They were used as an alternate
tumor mask for classifier training. Figure 4.6 shows these refined tumor masks. Additionally, a
breast tissue mask was also created manually to eliminate the chest and the background pixels.
The results for each subsequent phase of the experiment compare the effect of using these two
methods of ground truth selection.
4.4 3-Time Points Results
The 3-Time Points (3TP) method generates a three category classification used to indicate different
tiers of microvascular permeability. Of the three curve categories, Type II and Type III enhance-
ment curves indicate a “cancer-positive” condition, per pixel. Type I curves and non-enhancing
curves indicate a “cancer-free” condition, per pixel.
The canonical implementation of the 3TP method generates images with Type I, II, and III
curves as color-coded pixels. Any pixels that do not match one of the enhancement categories are
left uncolored (black). This instance of the 3TP method uses the first, second, and fifth time points
in each enhancement curve. Figure 4.7 shows these results.
The initial 3TP results, without post-processing, contained noise and artifacts throughout the
image. Because the intensity of green, or blue pixels is computed from the percent change between
the first and second time points, many background pixels show significant enhancement.
58
(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.5: K-means cluster result, with k = 7
59
(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.6: Tumor masks generated by clustering assisted method
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(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.7: Initial 3TP Results
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In Figure 4.7, this effect appears as halo of pixels that is either part of the background or within
the empty chest cavity. The lesions are indicated by a white area-of-interest box. Study D1 shows a
ring of Type I enhancement around a central area of non-enhancement, as does study D15. Studies
D2, D9, and D12 show central areas of Type II enhancement, surrounded by Type I enhancement.
Studies D11 and D16 show no enhancement in the lesion areas.
To approximate the results of the CADStream 3TP results, several operations were applied to
these images. First, a threshold for minimum enhancement was applied, where any pixels with
a 3TP value of less than 40% were set to zero. This threshold affected mostly background (non-
tissue) pixels. After applying a threshold, each study still contained a large proportion of pixels
that did not lie within the area-of-interest (AOI) but were identified as a Type I, II, or III curve.
Some of these pixels belonged to blood vessels in the breast tissue. These blood vessel pixels could
be distinguished by examining adjacent axial slices. The vessels show a connected structure in the
adjacent images and “travel” along the vessel.
The second operation applied to the image to remove these “vessel-pixels” was a median filter.
A 3×3 median filter was used to eliminate these single-pixel enhancements leaving larger, continu-
ous enhancement regions. A larger 5×5 median filter was also attempted, but may have decimated
too many pixels for the smaller lesions to be seen. For example, Study D16, only presented a small
spot of type I, II, and III on Figure 4.7. In Figure 4.8(g), this area has been eliminated, leaving
no significant group of pixels in the AOI. The second image operation applied was a 5×5 median
filter that eliminated any enhancing area less than approximately 4-pixels in area. Finally, the 3TP
images were clipped to the coronal plane, isolating only the breast tissue. Figure 4.8 presents the
post-processed 3TP results.
The 3TP method was also applied to the disease-negative images. The same threshold, median
filter, and clipping operations were applied. The disease-negative cases showed some enhancement
regions, but no structured enhancement as expected.
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(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16
Figure 4.8: Disease-positive 3TP results thresholded, filtered with a 5×5 median operation
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Table 4.1 summarizes the kinds of enhancement observed in each study. These results were
most similar to the CADStream result, but illustrates the necessary post-processing steps to elimi-
nate side effects such as noise and blood vessel enhancement.
Table 4.1: 3TP summary results
Study Type I Type II Type III Notes
D1 Yes Type II periphery, center does not enhance
D2 Yes Yes Type III center
D9 Yes Type III center
D11 No enhancement
D12 Yes Yes Type III center, Type II boundary
D15 Yes Type II center
D16 Minimal enhancement
The performance of the 3TP method as a classifier was computed by counting all Type II
and Type III curves as disease-positive classifications. Type I curves and non-enhancing pixels
were counted as disease-negative classifications. The predicted class was compared to the tumor
mask, and the performance statistics were computed. Balanced success was used to measure the
performance of the 3TP method due to the classes sizes being very unbalanced. In the training data,
there were 11,746 disease-positive examples (7.8390%) and 138,094 disease-negative examples
(92.161%). The balanced success rate was 52.617%, specificity 95.664%, and sensitivity 9.5692%.
4.5 Perfusion Parameter Recovery
Kernel recovery was performed on each of the stacked volumes with the following three ap-
proaches:
1. pseudoinverse with a sampled arterial input function,
2. pseudoinverse with a gamma variate curve, and
3. iterative blind deconvolution with a non-negative kernel constraint.
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For each disease positive study, a number of randomly chosen samples for three areas were
sampled: within the lesion boundary, outside of the lesion boundary, and inside the heart. Ten
samples for each area were gathered. Figure 4.9 shows the signal intensity plotted versus time in
seconds.
Studies D1, D2, D9, D12, D15, and D16 show that tumor pixels reach a higher level of en-
hancement than non-tumor pixels. Study D11 presents itself as a smaller signal strength.
The first deconvolution method used the sampled heart signal as the arterial input function.
The pseudoinverse operation was used to solve for the kernel. Each tissue kernel in these examples
showed an initial decrease in the value of the signal strength to a minimum point, followed by an
increase in value. According to the model of perfusion previously presented, the upslope of the
kernel function is not explained by the initial enhancement value, but is likely due to the extended
period of time that the signal lasts.
The second deconvolution used a fixed input function based on a gamma variate curve trans-
lated and scaled to fit the time scale and magnitude of the signal. Pseudoinversion was also used
for the kernel recovery. These results are shown on Figure 4.11.
The third deconvolution method employed blind deconvolution. The averaged cardiac signal
was used to initialize the blind convolution. Two constraints were applied on the kernel at each
iteration. First, the kernel was enforced to be non-negative (i.e., negative values were set to zero).
Second, the kernel series at each iteration was adjusted to non-increasing (i.e., any two adjacent
points on the kernel that exhibited an increase were replaced by the average of the two values).
















































































































































































































































































































































































































































































































































































Figure 4.12: Kernel recovered with gamma variate plus blind deconvolution
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4.6 Support Vector Machine Classification
With two different methods of tumor identification and three different approaches to deconvolution,
a tissue kernel function was computed from each pixel’s time series using the training data, and
marked with a “Cancer”/“Non-Cancer” training value. For each classification trial, the recovered







The first feature vector composition included only the enhancement signal. The second feature
vector composition appended the recovered kernel to the feature vector. The third feature vector
composition included the first derivative of the kernel vector and derived perfusion parameters of
flow and volume.
Three different SVM classification kernels were selected to classify each feature vector formu-
lation: a linear kernel, a polynomial kernel of order 2, and a Gaussian kernel. Ten-fold stratified
cross validation was used to measure the predictive performance of the SVM-based classifier on
each feature vector formulation. In each iteration of cross validation, the collection feature vectors
were randomly partitioned into a training and testing sets. Because it is stratified cross validation,
the number of examples for each class in each partition are kept proportional to the size of each
class in the total set. This is a preferred method of cross-validation, because the number of “Can-
cer” pixels are small in comparison to the number of “Non-Cancer” pixels. Each feature vector
was normalized to unit length prior to classification.
The first classification trial used feature vectors consisting only of the original signal data. One
copy of the training/testing set was marked with manually drawn tumor masks. The second set
was marked with clustering-assisted tumor masks. The SVM was trained using a linear kernel and
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the results are shown in Table 4.2. After 10-fold cross validation, the data set marked using the
assisted tumor masks showed an increase in balanced success, sensitivity, and specificity.
Table 4.2: Drawn tumor masks vs. assisted, feature vector 1, linear kernel
Statistic Drawn Assisted ∆%
Balanced Accuracy 69.33% 72.95% +3.62%
Sensitivity 75.82% 76.78% +0.96%
Specificity 62.84% 69.12% +6.28%
The second trial included only the training/testing set marked with cluster-assisted tumor masks.
Kernel recovery was performed using pseudoinverse deconvolution with a sampled cardiac arterial
input function. The original signal was combined with the recovered kernel as described in feature
vector pattern 2. The 10-fold cross validation was performed three times, varying the classification
kernel each time. The results of this trial are show in Table 4.3.
Table 4.3: Linear, quadratic, and Gaussian kernels, using assisted mask, feature vector 2
Statistic Linear Poly = 2 Gaussian
Accuracy 72.93% 74.61% 75.75%
Sensitivity 76.74% 76.46% 77.69%
Specificity 69.13% 72.76% 73.81%
Appending the kernel function to the feature vector with a linear classifier does not show an
improvement beyond one decimal place. However, between classification kernels, balanced suc-
cess, sensitivity, and specificity improve when using a quadratic classification kernel, and improve
even more using a Gaussian kernel.
In the third trial, the third formulation of the feature vector was trained and tested. Each
feature vector was marked using an assisted tumor mask, and a Gaussian kernel was employed.
The results are shown in Table 4.4. The results with this feature vector formulation shows an
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increase in balanced success and sensitivity, but a decrease in specificity when compared to the
Gaussian from Table 4.3.






To evaluate and visualize the performance of the SVM classifier using the derived tissue kernel
feature vector, several different schemes for training and classification were applied to the data.
Leave-one-out cross validation (LOOCV) was too computationally expensive to be practiced. In-
stead, the set of examples was divided by patient. Of the seven patients with tumors present, a
subset of 1 to 6 were chosen to train the SVM. This result was then used to classify the remaining
patients. Figure 4.13, shows the classification result from one example run in which feature vec-
tors generated from study D12 were used as the training set. The remaining studies were classified
with the support vector machine that resulted from this. The color coding used in Figure 4.13 to
represent true-positive red, true-negative green, false-positive blue, and false-negative yellow.
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(a) Study D1 (b) Study D2 (c) Study D9
(d) Study D11 (e) Study D12 (f) Study D15
(g) Study D16





The 3TP method produces majority classifications where most of the pixels are identified with
either no-enhancement or Type I curves. This is a common occurrence in the clinical application
of the 3TP method. Tumors which are identified by pathology do not exhibit Type II or Type III
enhancement curves. In light of this lack of detection sensitivity demonstrated by the first phase
of this research, there is a reliance on alternate modalities to improve a diagnosis. In fact, ultra-
sound and conventional X-ray mammography are examined in greater detail where morphology,
not enhancement behavior, is the primary diagnostic factor. With the standard tumor morphology
lexicon, the radiologist looks for common patterns such as spiculations.
In Figure 4.7, Studies D1, D11, D15, and D16 do not contain any Type II or Type III enhance-
ment curves. It should be noted that the cardiac space has Type III enhancement curves. This
is expected as the contrast agent circulates through the heart. Datasets D2, D9, and D12 do ex-
hibit Type III enhancement curves. The balanced performance of the 3TP method, even when the
washout tolerance was adjusted higher, has a very low detection sensitivity. These results were
visually compared to the Dynamics View in CADStream. Indeed, the same curve classifications
were made.
The Dynamics View in CADStream applied some additional filtering mimicked by the 5× 5
median filtering applied to the 3TP results. As in CADStream, this reduced many of the artifacts
attributable to signal noise. This is most apparent in study D9 comparing Figure 4.7(c) and Figure
4.8(c). There are many single-pixel “speckles” that are not part of a tumor or vasculature where
enhancement would be expected.
The balanced success rate of 3TP, 52.617%, reinforces that this method alone does not yield
much value in automated diagnosis. The low success rate could not be attributed to the limited
temporal resolution of the data, because the 3TP method only uses three time points.
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5.2 Cluster-Assisted Tumor Masks
The specification of ground truth using the software developed for the experiment showed a differ-
ence between the manual method and the cluster-assisted method. The manual method involved
the radiologist “painting” a mask over the approximate boundary of the tumor. The radiologist
could control the resolution of the marking tool and increase its zoom level to approximate the
boundary of the tumor. Other methods, such as 3-D mammography, could provide higher spatial
resolution to draw a more detailed boundary; however, the scope of this method is limited to the
single modality of contrast-enhanced MRI.
The K-means clustering algorithm differentiated groups of pixels without a model of behavior.
In visualizing the clustering result, however, it was useful to apply the central volume theorem.
Generally, areas with higher perfusion should yield a higher maximum value for K(t). A color
palette of green to yellow to red was used to indicate cluster classes that have a potentially high
level of blood flow. This result alone is not that useful for tumor classification. In Figure 4.5,
the tumors in D2, D9, and D11 have foci that need a manual discrimination from other pixels
belonging to the same cluster. Additional context was required to eliminate other pixels from
the tumors mask. From manual inspection of adjacent axial layers, some of these pixels were
identified with vasculature. In addition, other pixels were eliminated based on information from
in the radiologist’s report. For example, some lesions were identified in reports as non-cancerous
cysts or fibroadenoma.
The tumor in Figure 4.5, D16, did not show the typical enhancement pattern, as can be seen in
the 3TP result on Figure 4.8. This tumor also did not exhibit the highest degree of enhancement as
the other studies; however, the clustering algorithm still grouped these pixels. With morphological
evidence from the radiologist’s report, this was identified as a tumor.
The cluster-assisted method provided much more detail in the tumor mask. Selecting contigu-
ous areas of the same cluster group improved the specification of an actual tumor over manually
drawn masks in the following two ways:
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1. First, the tumor mask can be reproducibly created and is more consistent.
2. The model-free nature of the method allows some flexibility in determining which pixels are
part of the tumor.
Comparing the results of 10-fold cross validation between the manually drawn tumor masks
and the cluster-assisted method showed improvements in success rate and also in specificity and
sensitivity. Incorporating pathology, context clues, and morphology is the preferred method of
specifying the actual tumor than by simply drawing the tumor masks.
5.3 Methods of Perfusion Recovery
The accurate recovery of perfusion is inherently difficult because the arterial input function, CAIF(t),
cannot be measured at each pixel of computation. Therefore, an arterial input function must be ob-
tained in a way other than direct measurement. Breast tissue is also difficult to recover perfusion
in that few large arteries/veins are adjacent to where ductal carcinoma typical occurs. This is as
opposed to cerebral tissue where such physiology is present. Therefore, three different approaches
of arterial input selection were attempted.
1. Deconvolution with a fixed model curve as the arterial input function is often used in simu-
lated models of perfusion. The fixed set of parameters were chosen for the gamma variate
curve. The subsequent deconvolution result, placed in a feature vector, provided results that
out-performed classification with the control case.
2. The second approach to perfusion recovery used a sampled arterial input function from an
averaged sample of pixels from the heart. When incorporated into a feature vector in the
same fashion, it demonstrated higher performance versus the model curve.
3. Blind deconvolution was expected to have higher performance. Beginning with the sampled
input function as a seed, each iteration generated a new pair of kernel and input function
estimates. The rules used to refine the results at each iteration intended to isolate the ini-
tial enhancement, where the tissue kernel is monotonically decreasing. When added into
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a feature vector, this had the least performance of the two other methods of tissue kernel
recovery.
5.4 Performance of Adding Perfusion Data in Classification
The 3TP method is a standard technique to map the enhancement properties of tissue and provide
scale of microvascular permeability. The index of microvascular permeability is categorized into
one of three tissue classes, and applied as a diagnostic visualization in medical software such as
CADStream. In practice, the 3TP image product is not used as a diagnostic option in isolation.
Clinical radiologists improve their diagnostic accuracy by considering other forms of evidence
simultaneously. While this does improve diagnostic performance, the analysis time required per
study increases.
Classification algorithms can improve diagnostic performance by including the entire signal
curve, rather than only three time points. Perfusion recovery is used to quantify these physiological
parameters.
Relative perfusion parameters of flow, mean transit time, and volume are derived from the
kernel function of a unit of tissue by applying the convection-diffusion model of indicator particle
exchange. However, there are model-free properties of the kernel function that can be computed
and added to a feature vector for classification.
5.5 Conclusions
This research explored all the steps of breast cancer computer-aided diagnosis: image analysis,
tissue characterization, and cancer classification. Instead of relying on simulated data, this experi-
ment used real MRI studies. Many challenges were exposed and addressed with this “real-world”
context. We identify three main contributions from these results:
1. The addition of relative perfusion parameters via deconvolution improves classification per-
formance versus using only the enhancement information.
77
2. This approach to perfusion-based tissue classification out-performs the 3-Time Points method
employed in commercial-grade software tools.
3. Using an enhancement-based clustering method for segmentation to specify ground truth
improves classifier performance by reducing false training examples.
5.6 Future Work
The experimental method developed in this research exploited the data from the only diagnostic
protocol available, VIBRANT. Even with this grade of data, the results demonstrate some of the
improvements that are possible in computer aided breast cancer diagnosis. There are several steps
that warrant more exploration.
The effects of the low time resolution and extended period of measurement had an impact on
the perfusion recovery results. The method described here could have taken advantage of many
more time points as part of the image acquisition process. Most simulated processes use a time
step as small as one second. The experimental data used in this experiment had entire volumes
gathered at each time step. If spatial resolution could be sacrificed for temporal resolution, then
the perfusion results may have better performance.
Conversely, better spatial information could have been exploited by incorporating a way to look
at morphology. For example, after characterizing tumor pixels by perfusion, then a second stage
could be used to cluster pixels and generate a very accurate boundary for each cluster. A way to
automatically characterize the morphology of the cluster boundary could then be used to provide
a higher confidence prediction.
Texture has been incorporated into classifiers to detect patterns of malignant tumors. The
typical implementation is to transform a moving window of pixels into a feature vector, and then
perform training and classification on that population. Taking the results of this experiment, the
relative perfusion of several adjacent pixels within a window could be combined simultaneously
in a feature vector. Furthermore, better information, such as the gradient vector, could also be
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considered. This could potentially be used to identify the boundary of a tumor, and not rely on
clustering pixels that are independently computed.
One next step could be to implement elements of this research into a software-based tool in
a clinical setting. One challenge of developing such a tool is to communicate what the classifier
output means. One way of building trust in the diagnostic metric is to incorporate a measure
of uncertainty. By attributing a confidence level for each prediction, one can better interpret the
results as a diagnostic measure.
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Appendix: Datasets
Table A.1: Datasets for study, 15 ductal carcinoma, 6 negative, 9 unknown. Axis refers to ”clock-
face” position relative to the areola center
Dataset # Patient # Left/Right Axis Pathology
D1 P21 Right 9 ductal carcinoma
D2 P5 Right 9 ductal carcinoma
D3 P6 N/A N/A negative
D4 P16 N/A N/A negative
D5 P2 Right 8 unknown
D6 P11 Left 12 unknown
D7 P17 Right 1 unknown
D8 P25 Left 3 ductal carcinoma
D9 P19 Left 3 ductal carcinoma
D10 P3 Right 12 ductal carcinoma
D11 P26 Left Everywhere ductal carcinoma
D12 P10 Left Retroareolar ductal carcinoma
D13 P4 Right 11 unknown
D14 P7 N/A N/A negative
D15 P12 Left Retroareolar ductal carcinoma
D16 P22 Right 9 ductal carcinoma
D17 P27 Left Everywhere ductal carcinoma
D18 P8 N/A N/A negative
D19 P13 Left 7 unknown
D20 P24 Right 10 ductal carcinoma
D21 P23 Left Everywhere ductal carcinoma
D22 P29 Right Retroareolar unknown
D23 P9 N/A N/A unknown
D24 P15 Right 12 ductal carcinoma
D25 P14 Left 7 ductal carcinoma
D26 P28 Right Retroareolar unknown
D27 P18 Left 6 negative
D28 P20 Right 12 unknown
D29 P1 Right Retroareolar ductal carcinoma
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